Brief introduction of Zhejiang blood center

There are 197 employees in the center, including 16 with senior titles and 53 with intermediate titles, who enjoy 1 person in the State Council Special Post. The center consists of five administrative functional departments: office, personnel department, business department, finance department and general affairs department, and seven business departments, including quality management department, public relations department, physical examination and blood collection department, clinical blood transfusion service department, blood preparation and supply department, blood testing center and blood transfusion medicine research institute. Jiande Sub-station has two branches, Xiaoshan blood collection and supply point and Lin 'an blood collection point. Relying on the advantages of technology and equipment, Central Blood Transfusion Research Institute and Clinical Blood Transfusion Service Department have played the role of blood transfusion technical guidance center. Provide medical institutions in the province with: cryopreservation of umbilical cord blood hematopoietic stem cells; Collecting and freezing peripheral blood hematopoietic stem cells; Plasma exchange, red blood cell exchange; Pathological cell removal and other therapeutic apheresis; Intraoperative autotransfusion, assisted autotransfusion; Clinical blood transfusion technical consultation; Difficulties in blood group identification and matching; Molecular diagnosis of red blood cell, white blood cell and platelet blood group system; Diagnosis and matching of hemolytic disease of newborn; Tissue matching of bone marrow and organ transplantation; Detection of evidence of bone marrow transplantation.

Zhejiang Blood Center is the research, teaching and training center of blood transfusion medicine in Zhejiang Province, and attaches great importance to research and training. 10 Over the years, the center has completed 24 national key scientific research projects, national natural science foundation projects and provincial and ministerial scientific research projects, won 25 scientific research achievement awards, and published more than 250 papers in domestic and foreign journals, including 44 papers included in SCI. At present, it undertakes 9 scientific research projects, including National Natural Science Foundation 1 project and 2 key projects of Provincial Science and Technology Department.

In 200 1 year, the center was approved by the Ministry of Health [20065438+0] No.223, and established the "Zhejiang Cord Blood Hematopoietic Stem Cell Bank". There are more than 6000 umbilical cord blood hematopoietic stem cells in stock. Cooperate with clinical hospitals to complete many unrelated umbilical cord blood hematopoietic stem cell transplants.

In June 2004, blood transfusion medicine was included in the third batch of key medical construction disciplines in Zhejiang Province. From 2004 to 2008, the Central Research Group discovered about 40 new human HLA alleles.

Informatization is the basis of blood quality management and standardization. The center developed and built the first blood information network in provincial administrative regions in China, and realized the real-time exchange of blood data in the whole province. At the same time, we cooperated with "Zhejiang Blood Management and Control Information System BIS2.0" to develop and implement the key point control of blood business process quality, standardized the introduction of ISBT 128 blood coding standard, established the provincial blood system central database, and improved the blood safety in our province.

According to the "People's Republic of China (PRC) Blood Donation Law" and the functions entrusted by the provincial government and the provincial health department, the center will unite as one, fulfill its duties, persist in providing quality services for clinical practice, strive to establish a first-class blood center in China, and at the same time be in line with international standards, so as to make greater contributions to the development of blood industry in Zhejiang Province and benefit people's health.